BMJ 2003;327:28-29 (5 July), doi:10.1136/bmj.327.7405.28
Paper
Abstinence from smoking eight years after participation in randomised controlled trial of nicotine patch
Patricia Yudkin, reader in medical statistics1,
Kate Hey, research officer2,
Sarah Roberts, research nurse2,
Sarah Welch, research nurse2,
Michael Murphy, director2,
Robert Walton, senior research fellow3
1 Department of Primary Health Care, University of Oxford, Institute of Health
Sciences, Oxford OX3 7LF,
2 Cancer Research UK General Practice Research Group, Institute of Health
Sciences, Oxford OX3 7LF,
3 Department of Clinical Pharmacology, University of Oxford, Radcliffe
Infirmary, Oxford OX2 6HE
Correspondence to: P Yudkin
pat.yudkin{at}dphpc.ox.ac.uk
Introduction
Few studies have investigated abstinence beyond three years
among
participants who stop smoking during trials of nicotine
replacement
therapy,
13
and even fewer have followed
up
smokers who failed to quit during such trials.
We carried
out an eight year follow up of people who had participated in
a
randomised controlled trial of the nicotine patch.
Participants, methods, and results
Participants were the 1686 patients from general practices in
Oxfordshire
who took part in a double blind randomised controlled
trial of the patch in
1991-2.
4
5 At entry they
smoked

15
cigarettes a day and were aged 25-64 years. Participants wore
the
patches for 12 weeks. The main outcome was abstinence from
smoking for one
year, confirmed at 12, 24, and 52 weeks by
a salivary cotinine
concentration

20 ng/ml (89% of cases) or
expired carbon monoxide

10 ppm
(11%).
In 1999-2000, we contacted 1532 of the 1625 living participants. We sent
two follow up letters and phoned non-responders. In total 840 participants
completed a questionnaire giving demographic details and information about
smoking. The mean time from enrolment in the trial to follow up was 8.3 (SD
0.35) years, with a range of 7.4-9.3 years. Responders were more likely to be
women (59.0% v 51.7%; P=0.005) and were more likely to have stopped
smoking during the trial than non-responders (13.2% v 5.5% quit for
one year; P < 0.0001). Reported abstinence at follow up was confirmed by a
plasma cotinine concentration
20 ng/ml. Responders reported for how long
they had been abstinent. We assumed that all those lost to follow up were
still smoking.
Of the 153 participants who had stopped smoking for a year in the original
trial, 83 were still not smoking at follow up, giving an eight year abstinence
rate of 83/1625 (5%; 95% confidence interval 4% to 6%) and a relapse rate of
70/153 (46%; 38% to 54%)
(table). Relapse was similar in
active and placebo groups: the active/placebo odds ratio (OR) for continuous
abstinence up to follow up was 1.39 (0.89 to 2.17; P=0.19) compared with 1.45
(1.04 to 2.03; P=0.03) for quitting for a year in the trial.
View this table:
[in this window]
[in a new window]
|
Estimated smoking cessation at eight year follow up among trial
participants (n=1625). Values are numbers (percentage) of participants in each
trial group*
|
|
Of the 1472 who did not quit for a year in the trial, 116 (8%; 7% to 9%)
were abstinent at follow up. Of these, 89 (6%; 5% to 7%) had abstained for a
year or more, and 27 for less than a year (median 4 months). Overall at follow
up therefore, 172 (11%; 9% to 12%) of trial participants had been abstinent
for a year or more, 29 (2%) had been abstinent for less than a year, and 1424
(88%) were smoking.
Comment
Eight years after taking part in a randomised trial of the nicotine
patch,
just under half of the 9% who had stopped smoking for
a year had relapsed,
leaving 5% of all trial participants continuously
abstinent for eight years.
Previous studies have reported that
a third to a half of all those who stop
during a trial relapse
by three or four
years.
13
Use of the nicotine patch
conferred a 39% increase in the odds of continuous
abstinence
compared with placebo. The increase was not significant, but
our
original trial was not powered to detect the small difference
observed in
eight year abstinence rates (5.9%
v 4.3%). Of the
majority who did
not quit in the trial, only 8% had given up
smoking at follow up, leaving 88%
of trial participants still
smoking. Our estimates were based on the
conservative but well
accepted assumption that those lost to follow up were
still
smoking. Finding more effective ways to help people to give
up smoking
remains an ongoing challenge.
We thank Lesley Jones for computing help, and Elaine Johnstone
and Sian
Griffiths for cotinine analysis. Contributors: RW,
PY, and MM conceived the
study, wrote the protocol, and obtained
funding. KH traced the participants
and administered the study.
SR and SW collected the patient data and took
blood samples.
PY supervised data analysis and interpretation, drafted the
paper with contributions from all other authors, and is guarantor.
Funding: Cancer Research UK. The guarantor accepts full responsibility for
the conduct of the study, had access to the data, and controlled the decision
to publish.
Competing interests: None declared.
Ethical approval: Anglia and Oxford Multicentre Research Ethics Committee,
and 86 local research ethics committees.
References
- Blondal T, Gudmundsson LJ, Olafsdottir I, Gustavsson G, Westin A.
Nicotine nasal spray with nicotine patch for smoking cessation: randomised
trial with six year follow up. BMJ
1999;318:
285-9.[Abstract/Free Full Text]
- Stapleton JA, Sutherland G, Russell MAH. How much does relapse
after one year erode effectiveness of smoking cessation treatments? Long term
follow up of randomised trial of nicotine nasal spray.
BMJ 1998; 316:
830-1.[Free Full Text]
- Clavel-Chapelon F, Paoletti C, Benhamou S. Smoking cessation rates
4 years after treatment by nicotine gum and acupuncture. Prev
Med 1997;26:
25-8.[CrossRef][Medline]
- Imperial Cancer Research Fund General Practice Research Group.
Effectiveness of a nicotine patch in helping people to stop smoking: results
of a randomised trial in general practice. BMJ
1993;306:
1304-8.
- Imperial Cancer Research Fund General Practice Research Group.
Randomised trial of nicotine patches in general practice: results at one year.
BMJ 1994;308:
1476-7.[Free Full Text]
(Accepted March 6, 2003)

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Relevant Article
-
Effectiveness of nicotine patches is overstated
BMJ 2003 327: 0.
[Full Text]
This article has been cited by other articles:
-
Burke, M. V., Ebbert, J. O., Hays, J. T.
(2008). Treatment of Tobacco Dependence. Mayo Clin Proc.
83: 479-484
[Abstract]
[Full text]
-
Bauld, L., Judge, K., Platt, S.
(2007). Assessing the impact of smoking cessation services on reducing health inequalities in England: observational study. Tobacco Control
16: 400-404
[Abstract]
[Full text]
-
West, R., Zhou, X.
(2007). Is nicotine replacement therapy for smoking cessation effective in the "real world"? Findings from a prospective multinational cohort study. Thorax
62: 998-1002
[Abstract]
[Full text]
-
Bertram, M. Y, Lim, S. S, Wallace, A. L, Vos, T.
(2007). Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia. Tobacco Control
16: 255-260
[Abstract]
[Full text]
-
Kvasnicka, J.
(2007). Priorities to Improve Health Outcomes. JAMA
297: 2346-2346
[Full text]
-
Gordon, L., Graves, N., Hawkes, A., Eakin, E.
(2007). A review of the cost-effectiveness of face-to-face behavioural interventions for smoking, physical activity, diet and alcohol. Chronic Illness
3: 101-129
[Abstract]
-
Etter, J.-F., Stapleton, J. A
(2006). Nicotine replacement therapy for long-term smoking cessation: a meta-analysis.. Tobacco Control
15: 280-285
[Abstract]
[Full text]
-
(2003). Nicotine Patches: Not So Effective in the Long Run. Journal Watch Dermatology
2003: 9-9
[Full text]
-
(2003). Nicotine Patches: Not So Effective in the Long Run. Journal Watch Cardiology
2003: 5-5
[Full text]
-
(2003). Nicotine Patches: Not So Effective in the Long Run. JWatch General
2003: 4-4
[Full text]
Rapid Responses:
Read all Rapid Responses
- Does nicotine replacement therapy help smokers quit?
- Martin J Butcher
bmj.com, 10 Jul 2003
[Full text]
- Lessons for clinical practice and research
- John A Stapleton, et al.
bmj.com, 11 Jul 2003
[Full text]
- Re: Does nicotine replacement therapy help smokers quit?
- John A Stapleton
bmj.com, 16 Jul 2003
[Full text]
- Report presents the “worst-case” scenario for trial participants
- Lincoln A Sargeant, et al.
bmj.com, 18 Jul 2003
[Full text]
- Response from authors
- Patricia Yudkin, et al.
bmj.com, 24 Jul 2003
[Full text]
- Re: Re: Does nicotine replacement therapy help smokers quit?
- Martin J Butcher
bmj.com, 25 Jul 2003
[Full text]
- Unrealistic expectation leads to disappointment
- John Bery
bmj.com, 30 Jul 2003
[Full text]
- Re: Does nicotine replacement therapy help smokers quit?
- John R. Polito
bmj.com, 30 Jul 2003
[Full text]
- What happened to their weight 8 years after nicotine patch treatment?
- Deborah Lycett, et al.
bmj.com, 7 May 2009
[Full text]